[Dysfunction of the nitric oxide pathway during coronary endothelium regeneration]

Paul M Vanhoutte1, Marie-Pierre Fournet-Bourguignon, Jean-Paul Vilaine

  • 1Hôpital Pitié-Salpêtrière, 47 boulevard de l'Hôpital, 75651 Paris.

Insights

Aging and increased cell density impair endothelial function. Regenerated pig coronary cells showed reduced responses to bradykinin and A23187, indicating endothelial dysfunction due to cell senescence and higher density.

Area of Science:

  • Vascular Biology
  • Cellular Physiology
  • Endothelial Function

Context:

  • Endothelial dysfunction is observed during regeneration after injury.
  • Reduced endothelium-dependent relaxation to bradykinin is a key indicator.
  • The roles of aging and cellular density in this dysfunction are not fully understood.

Purpose:

  • To investigate the effects of aging and cellular density on endothelial NO-synthase (eNOS) activity in pig coronary endothelial cells.
  • To determine if cellular senescence or increased cell density contributes to impaired endothelial function during regeneration.

Summary:

  • Cultured regenerated endothelium showed normal cyclic GMP but reduced responses to bradykinin and A23187.
  • Cellular passages mimicking aging led to decreased basal cyclic GMP and reduced bradykinin response.
  • Increased cellular density reduced active eNOS sites and nitric oxide production.

Impact:

  • Findings suggest both cell senescence and increased density contribute to endothelial dysfunction post-regeneration.
  • This research enhances understanding of vascular reactivity changes and pathological consequences during endothelial regeneration.
  • Provides insights into mechanisms underlying impaired vascular function in aging and injury contexts.

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...